| This page is intended for physicians and research scientists.
ISSUE: 2002/03/a
To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine.
After viewing the abstract use your browser's [Back] button to return to this page.
- Contents
 References: Clinical / Prognostic Markers
- References: Basic Science / Neuroblastoma Research
- References: Neurobiology / Cell Physiology Research (neuroblastoma cell lines)
- Previous Issue of Recent Publications (2002/02/a)
- Next Issue of Recent Publications (2002/04/a)
- Back to NBL-PROF Home Page
Clinical / Prognostic Markers
Basic Science / Neuroblastoma Research
Abel F, et al.
Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.
Br J Cancer 2002 Feb 12;86(4):596-604
[Related articles]  Chromosome 1p
| Beierle EA, et al.
Insulin-like growth factor-I protects neuroblastoma against starvation-induced apoptosis and is associated with increased Bcl-2 expression.
J Pediatr Surg 2002 Mar;37(3):472-6
[Related articles] | Casciano I, et al.
Role of methylation in the control of DeltaNp73 expression in neuroblastoma.
Cell Death Differ 2002 Mar;9(3):343-5
[Related articles] | Cerignoli F, et al.
retSDR1, a Short-Chain Retinol Dehydrogenase/Reductase, Is Retinoic Acid-inducible and Frequently Deleted in Human Neuroblastoma Cell Lines.
Cancer Res 2002 Feb 15;62(4):1196-204
[Related articles] | Decaudin D, et al.
Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo.
Cancer Res 2002 Mar 1;62(5):1388-93
[Related articles] | Dotsch J, et al.
Diagnostic and scientific applications of TaqMan real-time PCR in neuroblastomas.
Expert Rev Mol Diagn 2001; 1(2):233-8
[Related articles] | Eggert A, et al.
Expression of the Neurotrophin Receptor TrkA Down-Regulates Expression and Function of Angiogenic Stimulators in SH-SY5Y Neuroblastoma Cells.
Cancer Res 2002 Mar 15;62(6):1802-8
[Related articles] | Iehara T, et al.
Cytogenetic analysis of infantile neuroblastomas by comparative genomic hybridization.
Cancer Lett 2002 Apr 8;178(1):83-9
[Related articles] | Krams M, et al.
Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Cancer 2002 Feb 1;94(3):854-61
[Related articles] MYCN Amplification
| Mora J, et al.
Novel Regions of Allelic Imbalance Identified by Genome-wide Analysis of Neuroblastoma.
Cancer Res 2002 Mar 15;62(6):1761-7
[Related articles] | Perel Y, et al.
Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status.
Br J Cancer 2002 Jan 7;86(1):117-22
[Related articles] | Sela B.
[Survivin: anti-apoptosis protein and a prognostic marker for tumor progression and recurrence]
Harefuah 2002 Jan;141(1):103-7, 123
[Related articles] | Shohet JM, et al.
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
Cancer Res 2002 Feb 15;62(4):1123-8
[Related articles] MYCN Amplification
| Sotiriou C, et al.
Core Biopsies Can Be Used to Distinguish Differences in Expression Profiling by cDNA Microarrays.
J Mol Diagn 2002 Feb;4(1):30-36
[Related articles] | Teitz T, et al.
Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN.
Oncogene 2002 Mar 14;21(12):1848-58
[Related articles] MYCN Amplification Chromosome 1p
| Thomas PB, et al.
Effective targeted cytotoxicity of neuroblastoma cells.
J Pediatr Surg 2002 Mar;37(3):539-44
[Related articles] |
Neurobiology / Cell Physiology Research (neuroblastoma cell lines)
Previous Issue of Recent Publications (2002/02/a)
Next Issue of Recent Publications (2002/04/a)
Back to NBL-PROF Home Page
|
